Holen Sie sich die Stockscreener-App
193.03
0.72%
-1.40
Handel nachbörslich:
193.03
Charles River Laboratories International Inc Aktie (CRL) Neueste Nachrichten
Charles River Laboratories (CRL): Reassessing Valuation After a Quiet Share Price Rebound - Sahm
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort - PharmiWeb.com
Pre-clinical trial giant eyes organ-on-a-chip companies after activist investor pressure - The Business Journals
What's Driving the Market Sentiment Around Charles River Laboratories International Inc? - Benzinga
Charles River Laboratories International, Inc. $CRL Shares Acquired by Bank of Nova Scotia - MarketBeat
Invesco Ltd. Purchases 128,785 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Burgundy Asset Management Ltd. Buys 277,450 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Russell Investments Group Ltd. Buys 11,667 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
What Charles River Laboratories International (CRL)'s Strengthening DSA Bookings Trend Means For Shareholders - Yahoo Finance
Charles River Laboratories Tops Q3 Estimates, Tightens Full-Year Outlook - MSN
Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2025 Earnings Call Transcript - MSN
Edgestream Partners L.P. Invests $1.80 Million in Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories credit outlook lowered to stable at S&P on weak 2025 guidance - MSN
Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors - MSN
Kennedy Capital Management LLC Lowers Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
Norges Bank Makes New Investment in Charles River Laboratories International, Inc. $CRL - MarketBeat
What Charles River Laboratories International (CRL)'s Improving Discovery and Safety Assessment Bookings Trend Means For Shareholders - simplywall.st
Why Charles River Laboratories International Inc. stock is recommended by analystsGold Moves & Short-Term Trading Alerts - Newser
Will Charles River Laboratories International Inc. (RV6) stock split increase liquidityJuly 2025 Levels & High Accuracy Buy Signal Tips - Newser
Charles River Laboratories International Earnings Notes - Trefis
Why Charles River Laboratories International Inc. stock could break out in 2025Market Trend Report & Capital Efficiency Focused Strategies - Newser
Charles River Laboratories (CRL) Stock Declines Amid FDA Announcement - GuruFocus
Can Charles River Laboratories International Inc. (RV6) stock test all time highsQuarterly Market Review & Low Volatility Stock Recommendations - Newser
CROs fall as FDA head Makary says drug approvals will require fewer trials ( - Seeking Alpha
New York State Common Retirement Fund Reduces Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
What analyst consensus implies for Charles River Laboratories International Inc. stock2025 Major Catalysts & High Yield Equity Trading Tips - Newser
What insider trading reveals about Charles River Laboratories International Inc. stockEarnings Summary Report & Weekly High Potential Stock Alerts - Newser
How strong is Charles River Laboratories International Inc. (RV6) stock earnings growthWeekly Market Report & Low Risk Entry Point Guides - Newser
Arrowstreet Capital Limited Partnership Purchases 225,027 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Labs Joins Evercore Healthcare Conference - The Globe and Mail
Charles River Laboratories International, Inc. (NYSE:CRL) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MSN
Charles River Laboratories (CRL) Shares Skyrocket, What You Need To Know - Finviz
CRL Stock Rises on Improved DSA Demand & Upward Trends | Dec 2025News and Statistics - IndexBox
Transcript : Charles River Laboratories International, Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-03-2025 10 - marketscreener.com
Charles River Laboratories (CRL) Updates on Fourth-Quarter Deman - GuruFocus
Charles River Laboratories International IncDSA Net Book-to-Bill Improved Each Month Since Q3 2025SEC Filing - marketscreener.com
Charles River Laboratories Updates on DSA Trends at Conference - TradingView
Charles River Laboratories (NYSE: CRL) reports improving DSA net book-to-bill trends - Stock Titan
Is Charles River Laboratories International Inc. stock undervalued by metrics2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
JPMorgan Chase & Co. Sells 481,286 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
How Charles River Laboratories International Inc. stock performs in stagflationPortfolio Risk Report & Weekly High Potential Stock Alerts - Newser
Is Charles River Laboratories International Inc. stock vulnerable to rate hikesJuly 2025 Update & Safe Entry Point Alerts - Newser
Will Charles River Laboratories International Inc. (RV6) stock announce special dividend2025 Earnings Impact & Weekly Market Pulse Updates - Newser
Jefferies Adjusts PT on Charles River Laboratories International to $205 From $200, Maintains Buy Rating - marketscreener.com
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - Lelezard
Will Charles River Laboratories International Inc. stock benefit from sector rotationJuly 2025 PreEarnings & Growth-Oriented Investment Plans - Newser
SG Americas Securities LLC Sells 265,740 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Morgan Stanley assumes coverage of Charles River Labs stock with Equalweight rating - Investing.com Canada
Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATI - GuruFocus
1.15%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):